These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7966218)

  • 21. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
    Schlievert PM
    J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of magnesium on in vitro production of toxic shock syndrome toxin 1.
    James JF; Chu MC; Lee L; Peck SA; McKissick C; Sullivan H; Frogner K; Melish M
    Rev Infect Dis; 1989; 11 Suppl 1():S157-66. PubMed ID: 2928632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Lee AC; Crass BA; Bergdoll MS
    J Clin Microbiol; 1987 Jan; 25(1):87-90. PubMed ID: 3793877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cases of menstrual toxic shock syndrome in the Czech Republic in 1997-2011].
    Petrás P; Machová I; Rysková L; Prásil P
    Epidemiol Mikrobiol Imunol; 2011 Nov; 60(4):161-6. PubMed ID: 22324245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous occurrence of Staphylococcus aureus mutants with different pigmentation and ability to produce toxic shock syndrome toxin 1.
    Lee AC; Bergdoll MS
    J Clin Microbiol; 1985 Aug; 22(2):308-9. PubMed ID: 4031043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MRSA infection and toxic shock syndrome in burn patients].
    Kato K; Tanaka T
    Nihon Rinsho; 1992 May; 50(5):1104-11. PubMed ID: 1507435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation and control of toxic shock syndrome toxin 1: overview.
    Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S142-4. PubMed ID: 2648538
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxic shock syndrome--the role of the toxin.
    Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
    Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus.
    Holland KT; Taylor D; Farrell AM
    J Antimicrob Chemother; 1994 Jan; 33(1):41-55. PubMed ID: 8157573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A patient with toxic shock syndrome following correction of the nasal septum].
    Schweitzer DH; Moffie BG; van der Mey AG; Thompson J
    Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2146-8. PubMed ID: 2247173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
    Todd JK; Todd BH; Franco-Buff A; Smith CM; Lawellin DW
    J Infect Dis; 1987 Apr; 155(4):673-81. PubMed ID: 3546518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis.
    Sarafian SK; Morse SA
    J Med Microbiol; 1987 Aug; 24(1):75-81. PubMed ID: 3612745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
    Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
    J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML; Kum WW; Chow AW
    Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of coagulase-negative staphylococci in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Clin Microbiol; 1986 Jan; 23(1):43-5. PubMed ID: 3700606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus restricted to endogenous air in tampons.
    Reiser RF; Hinzman SJ; Bergdoll MS
    J Clin Microbiol; 1987 Aug; 25(8):1450-2. PubMed ID: 3624443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers.
    Humphreys H; Keane CT; Hone R; Pomeroy H; Russell RJ; Arbuthnott JP; Coleman DC
    J Med Microbiol; 1989 Mar; 28(3):163-72. PubMed ID: 2926789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecology of toxic shock syndrome: amplification of toxic shock syndrome toxin 1 by materials of medical interest.
    Tierno PM; Hanna BA
    Rev Infect Dis; 1989; 11 Suppl 1():S182-6; discussion S186-7. PubMed ID: 2928635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci.
    Parsonnet J; Harrison AE; Spencer SE; Reading A; Parsonnet KC; Kass EH
    J Clin Microbiol; 1987 Aug; 25(8):1370-2. PubMed ID: 3624436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.